Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease

Cell Host and Microbe

Volumn 7, Issue 2, 2010, Pages 128-139

  Zellweger, Raphaël M ^a   Prestwood, Tyler R ^a   Shresta, Sujan ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

MICROBIO

Indexed keywords

VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DENGUE; DISEASE EXACERBATION; DISEASE SEVERITY; ENDOTHELIUM CELL; FATALITY; HUMORAL IMMUNITY; IMMUNOREACTIVITY; INFECTION PREVENTION; LIVER CELL; LIVER SINUSOID; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; ENDOTHELIAL CELLS; LIVER; MICE; SURVIVAL ANALYSIS;

ANIMALIA; DENGUE VIRUS; MUS;

EID: 76249103868     PISSN: 19313128     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chom.2010.01.004     Document Type: Article

References (39)

1. Balsitis S.J., Coloma J., Castro G., Alava A., Flores D., McKerrow J.H., Beatty P.R., and Harris E. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am. J. Trop. Med. Hyg. 80 (2009) 416-424
2. Bashirova A.A., Geijtenbeek T.B., van Duijnhoven G.C., van Vliet S.J., Eilering J.B., Martin M.P., Wu L., Martin T.D., Viebig N., Knolle P.A., et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J. Exp. Med. 193 (2001) 671-678
3. Blackley S., Kou Z., Chen H., Quinn M., Rose R.C., Schlesinger J.J., Coppage M., and Jin X. Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J. Virol. 81 (2007) 13325-13334
4. Boonnak K., Slike B.M., Burgess T.H., Mason R.M., Wu S.J., Sun P., Porter K., Rudiman I.F., Yuwono D., Puthavathana P., et al. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J. Virol. 82 (2008) 3939-3951
5. Brooks D.G., Trifilo M.J., Edelmann K.H., Teyton L., McGavern D.B., and Oldstone M.B. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12 (2006) 1301-1309
6. Burton D.R. Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2 (2002) 706-713
7. Chaturvedi U.C., Agarwal R., Elbishbishi E.A., and Mustafa A.S. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol. Med. Microbiol. 28 (2000) 183-188
8. Chiu Y.C., Wu K.L., Kuo C.H., Hu T.H., Chou Y.P., Chuah S.K., Kuo C.M., Kee K.M., Changchien C.S., Liu J.W., et al. Endoscopic findings and management of dengue patients with upper gastrointestinal bleeding. Am. J. Trop. Med. Hyg. 73 (2005) 441-444
9. Diamond M.S., Edgil D., Roberts T.G., Lu B., and Harris E. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol. 74 (2000) 7814-7823
10. Elvevold K., Smedsrod B., and Martinez I. The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity. Am. J. Physiol. 294 (2008) G391-G400
11. Goncalvez A.P., Engle R.E., St Claire M., Purcell R.H., and Lai C.J. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc. Natl. Acad. Sci. USA 104 (2007) 9422-9427
12. Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Lew R., Innis B.L., Kurane I., Rothman A.L., et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 179 (1999) 755-762
13. Halstead S.B. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Infect. Dis. 140 (1979) 527-533
14. Halstead S.B. Immune enhancement of viral infection. Prog. Allergy 31 (1982) 301-364
15. Halstead S.B. Neutralization and antibody-dependent enhancement of dengue viruses. Adv. Virus Res. 60 (2003) 421-467
16. Halstead S.B. Dengue. Lancet 370 (2007) 1644-1652
17. Halstead S.B., Nimmannitya S., Yamarat C., and Russell P.K. Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn. J. Med. Sci. Biol. 20 Suppl (1967) 96-103
18. Halstead S.B., O'Rourke E.J., and Allison A.C. Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J. Exp. Med. 146 (1977) 218-229
19. Jessie K., Fong M.Y., Devi S., Lam S.K., and Wong K.T. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J. Infect. Dis. 189 (2004) 1411-1418
20. Jones M., Davidson A., Hibbert L., Gruenwald P., Schlaak J., Ball S., Foster G.R., and Jacobs M. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J. Virol. 79 (2005) 5414-5420
21. Katz S.C., Pillarisetty V.G., Bleier J.I., Shah A.B., and DeMatteo R.P. Liver sinusoidal endothelial cells are insufficient to activate T cells. J. Immunol. 173 (2004) 230-235
22. Kittigul L., Pitakarnjanakul P., Sujirarat D., and Siripanichgon K. The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection. J. Clin. Virol. 39 (2007) 76-81
23. Kou Z., Quinn M., Chen H., Rodrigo W.W., Rose R.C., Schlesinger J.J., and Jin X. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J. Med. Virol. 80 (2008) 134-146
24. Lambeth C.R., White L.J., Johnston R.E., and de Silva A.M. Flow cytometry-based assay for titrating dengue virus. J. Clin. Microbiol. 43 (2005) 3267-3272
25. Mehlhop E., Ansarah-Sobrinho C., Johnson S., Engle M., Fremont D.H., Pierson T.C., and Diamond M.S. Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Cell Host Microbe 2 (2007) 417-426
26. Miller J.L., deWet B.J., Martinez-Pomares L., Radcliffe C.M., Dwek R.A., Rudd P.M., and Gordon S. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog. 4 (2008) e17 10.1371/journal.ppat.0040017
27. Munoz-Jordan J.L., Sanchez-Burgos G.G., Laurent-Rolle M., and Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. USA 100 (2003) 14333-14338
28. Pierson T.C., and Diamond M.S. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev. Mol. Med. 10 (2008) e12
29. Pierson T.C., Xu Q., Nelson S., Oliphant T., Nybakken G.E., Fremont D.H., and Diamond M.S. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe 1 (2007) 135-145
30. Prestwood T.R., Prigozhin D.M., Sharar K.L., Zellweger R.M., and Shresta S. A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads. J. Virol. 82 (2008) 8411-8421
31. Rico-Hesse R. Dengue virus evolution and virulence models. Clin. Infect. Dis. 44 (2007) 1462-1466
32. Rosen L., Drouet M.T., and Deubel V. Detection of dengue virus RNA by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection. Am. J. Trop. Med. Hyg. 61 (1999) 720-724
33. Rothman A.L. Immunology and immunopathogenesis of dengue disease. Adv. Virus Res. 60 (2003) 397-419
34. Shresta S., Sharar K.L., Prigozhin D.M., Beatty P.R., and Harris E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J. Virol. 80 (2006) 10208-10217
35. Starnes Jr. H.F., Pearce M.K., Tewari A., Yim J.H., Zou J.C., and Abrams J.S. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J. Immunol. 145 (1990) 4185-4191
36. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M.A., Pattanapanyasat K., Sarasombath S., Birx D.L., et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197 (2003) 823-829
37. Uematsu S., Fujimoto K., Jang M.H., Yang B.G., Jung Y.J., Nishiyama M., Sato S., Tsujimura T., Yamamoto M., Yokota Y., et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 9 (2008) 769-776
38. Whitehead S.S., Blaney J.E., Durbin A.P., and Murphy B.R. Prospects for a dengue virus vaccine. Nat. Rev. 5 (2007) 518-528
39. Young D.F., Chatziandreou N., He B., Goodbourn S., Lamb R.A., and Randall R.E. Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J. Virol. 75 (2001) 3363-3370